Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business

Go back to Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business

Stryker (SYK) PT Raised to $416 at BTIG

January 29, 2025 6:06 AM EST

BTIG analyst Ryan Zimmerman raised the price target on Stryker (NYSE: SYK) to $416.00 (from $394.00) while maintaining a Buy rating.

The analyst comments "We maintain our Buy rating and raise our PT to $416 PT (from $394) following 4Q24 results. SYK delivered strong diversified results in 4Q24 with rev. of $6.436B... More